Cargando…
Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis
BACKGROUND: Multiple sclerosis (MS) is a widespread neurological autoimmune disease that includes episodes of demyelination in the central nervous system (CNS). The accumulated evidence has suggested that aryl hydrocarbon receptor (Ahr), a ligand-activated transcription factor, is a promising treatm...
Autores principales: | Abdullah, Alzahrani, Maged, Mohammed, Hairul-Islam M., Ibrahim, Osama I., Alwassil, Maha, Habash, Manal, Alfuwaires, Hamza, Hanieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485712/ https://www.ncbi.nlm.nih.gov/pubmed/31026283 http://dx.doi.org/10.1371/journal.pone.0215981 |
Ejemplares similares
-
Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells
por: Hanieh, Hamza, et al.
Publicado: (2016) -
Correction: Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis
Publicado: (2019) -
Aryl Hydrocarbon Receptor as an Anticancer Target: An Overview of Ten Years Odyssey
por: Hanieh, Hamza, et al.
Publicado: (2023) -
Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor
por: Shen, Pei-Xin, et al.
Publicado: (2021) -
Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis
por: Alzahrani, Abdullah, et al.
Publicado: (2020)